Hepatitis Clinical Trials

Showing 121-140 of 1,819 trials

SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.

NCT05461170

This is a phase 2 trial in which participants with chronic hepatitis D virus (HDV) infection will receive VIR-2218 and/or VIR-3434 and be assessed for safety, tolerability, and efficacy

Hepatitis D, Chronic

Vir Biotechnology, Inc.95 participantsStarted Sep 2022

Sofia, Bulgaria • Sofia, Bulgaria • Stara Zagora, Bulgaria +17 more locations

Active Not RecruitingPhase 3

Reducing Vertical Transmission of Hepatitis B in Africa

NCT04704024

Hepatitis B virus is an infection that can be easily transmitted from women to newborns at the time of delivery. Our objective is to identify novel options that are effective and safe in preventing perinatal transmission of hepatitis B in Africa. The REVERT-B study (Reducing Vertical Transmission of Hepatitis B in Africa) is a clinical trial designed to test a new strategy of using antiviral medication in high-risk pregnant women and newborns to reduce the risk of hepatitis B transmission. The study will measure efficacy, safety, tolerability and adherence to medication.

Hepatitis B Infection

University of Alabama at Birmingham450 participantsStarted Sep 2021

Birmingham, Alabama, United States

SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.

Reducing Vertical Transmission of Hepatitis B in Africa

Related Searches

Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH

Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion

Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis B

Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B

Study of ADI-PEG 20 Versus Placebo in Subjects With NASH

Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand

A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection

A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis

Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease

Integrated Treatment of Hepatitis C Virus Infection

Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids

Using Flavonoids to Kill Hepatitis B Virus

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Community Intervention to Eliminate HCV Among People Who Use Drugs.

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

Huazhi Rougan Granule as an Add-On Therapy for H. Pylori Infection With Metabolic-associated Steatohepatitis

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes